Obesity Strategic Roundup: Emerging Competition | Oct 5 – Nov 6 , 2026
Obesity market competition is expanding beyond weight-loss efficacy as…
Obesity Strategic Roundup: Beyond GLP-1 Efficacy | Sep 1 – Oct 4 , 2026
How are next-generation obesity therapies reshaping competition in the GLP-1…
Obesity Strategic Roundup | Jul 28 – Aug 31 , 2026
Obesity Strategic Roundup exploring Developments and Competitive Shifts…
Obesity Strategic Roundup | June 22–July 27, 2026
Obesity Strategic Roundup exploring Developments and Competitive Shifts…
Nurix Roche Bexobrutideg Deal | Lucid Diligence Brief
Roche’s collaboration with Nurix turns bexobrutideg into a multi-indication BTK…
Servier Edgewise Sevasemten Deal | Lucid Diligence Brief
Servier’s Edgewise acquisition puts sevasemten’s Becker muscular dystrophy data…
Lucid Diligence Brief: Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery
Lucid Diligence Brief: Incyte and Genesis Molecular AI expand collaboration…
Biosimilars on the rise: they are just getting started
Biologics have revolutionized the management of previously intractable…